Status:
ACTIVE_NOT_RECRUITING
HEALing Communities Study
Lead Sponsor:
RTI International
Collaborating Sponsors:
Boston Medical Center
Columbia University
Conditions:
Opioid Use Disorder (OUD)
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study will test the impact of implementing the Communities That Helping to End Addiction Long-term (HEAL) intervention on opioid overdose deaths within 67 highly affected communities with the goa...
Detailed Description
The HEALing Communities Study (HCS) is a multi-site, parallel group, cluster randomized wait-list controlled trial to test the impact of the Communities That HEAL (CTH) intervention, which is designed...
Eligibility Criteria
Inclusion
- The community must be located in one of the four participating states: Kentucky, Ohio, Massachusetts, or New York.
- At least 30% of the communities selected within each state must be rural.
- Across all the HCS communities within each state, there must be a minimum of 150 opioid-related overdose fatalities (with at least 22 opioid-related overdose fatalities experienced by the rural communities) and a rate of at least 25 opioid-related overdose fatalities per 100,000 persons, based on 2016 data.
- The community must express willingness to address in their response strategy the implementation of MOUD, overdose prevention training, and naloxone distribution across their community.
- The community must express willingness to develop partnerships across health care, behavioral health, and justice settings for evidence-based practices to address opioid misuse, OUD, and overdoses.
Exclusion
- Communities that did not meet the aforementioned inclusion criteria were excluded from the HCS.
Key Trial Info
Start Date :
October 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2025
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT04111939
Start Date
October 23 2019
End Date
September 30 2025
Last Update
May 29 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40508
2
Boston Medical Center
Boston, Massachusetts, United States, 02118
3
Columbia University
New York, New York, United States, 10027
4
Ohio State University
Columbus, Ohio, United States, 43210